compound introduction
FX-909 is a covalent peroxisome proliferator-activated receptor gamma ( PPARG ) inverse agonist. FX-909 can be used for the research of cancer In Vivo FX-909 (0.03-1 mg/kg; BID for 21 days) shows anticancer effects in UMUC9 UC xenograft mouse model . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:PPARγ
